• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    More On BIOCON.BO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Biocon Limited (BIOCON.BO)

    -BSE
    417.15 Up 3.95(0.96%) Dec 26, 5:21AM EST
    Add to Portfolio
    Prev Close:413.20
    Open:412.95
    Bid:417.15
    Ask:418.90
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:412.00 - 418.90
    52wk Range:408.05 - 553.70
    Volume:73,765
    Avg Vol (3m):82,163
    Market Cap:81.87B
    P/E (ttm):19.68
    EPS (ttm):21.20
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in INR.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.78
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biocon Limited develops and sells biotechnology products for the pharmaceutical sector in India and internationally. It offers active pharmaceutical ingredients, including cardiovascular agents, anti-obesity agents, immunosuppressants, opthalmics,... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback